Clay Siegall is the CEO of Seattle Genetics. (Dan Bates / Herald file)

Clay Siegall is the CEO of Seattle Genetics. (Dan Bates / Herald file)

Bothell’s Seattle Genetics to acquire Cascadian Therapeutics for $614M

Deal would be merger between two Puget Sound area biotech companies developing cancer treatments.

BOTHELL — Seattle Genetics has reached a deal to acquire Seattle-based Cascadian Therapeutics for $614 million, or $10 per share in cash.

Cascadian Therapeutics’ most advanced program is a drug in clinical trials to treat breast cancer. The drug is called tucatinib.

Clay Siegall, CEO of Seattle Genetics, which is based in Bothell, said the acquisition gives his company a “potentially best-in-class, orally available” drug to treat the cancer. Seattle Genetics is the maker of Adcetris, an on the market drug which is used to treat Hodgkin lymphoma.

“Tucatinib would complement our existing pipeline of targeted cancer therapies, provide a third late-stage opportunity for a commercial product in solid tumors and expand our global efforts in breast cancer,” said Siegall, in a statement. “It also leverages our broad expertise and resources to advance and expand the tucatinib program for patients.”

The deal caused stock for Cascadian Therapeutics, which trades under the ticker symbol CASC, stock to jump from $5.90 on Tuesday to $10.06 a share at close on Wednesday.

Seattle Genetics, which trades under the ticker symbol SGEN, saw its stock drop $55.21 to $52.30 a share or a loss of 5.27 percent.

Cascadian Therapeutics CEO Scott D. Myers said the deal is a positive outcome for patients, his employees and Cascadian Therapeutics stockholders.

“Seattle Genetics has the development and commercial capabilities and the resources needed to more fully realize the potential of tucatinib as a new best-in-class treatment option for metastatic breast cancer, colorectal cancer and potentially for other indications,” Myer said.

For the acquisition, Seattle Genetics has secured a financing commitment in the amount of $400 million from Barclays and JPMorgan-Chase Bank. The balance of the consideration will be provided from cash on hand.

Last summer, Seattle Genetics spent $43.3 million to purchase a pharmaceutical manufacturing plant in Bothell. A year ago, Seattle Genetics terminated a $2 billion deal to purchase New Jersey-based biotech firm Immunomedics, which was developing treatments for breast, lung and bladder cancers.

Jim Davis: 425-339-3097; jdavis@heraldnet.com; @HBJnews.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Business

Lily Lamoureux stacks Weebly Funko toys in preparation for Funko Friday at Funko Field in Everett on July 12, 2019.  Kevin Clark / The Herald)
Everett-based Funko ousts its CEO after 14 months

The company, known for its toy figures based on pop culture, named Michael Lunsford as its interim CEO.

The livery on a Boeing plane. (Christopher Pike / Bloomberg)
Former Lockheed Martin CFO joins Boeing as top financial officer

Boeing’s Chief Financial Officer is being replaced by a former CFO at… Continue reading

Izaac Escalante-Alvarez unpacks a new milling machine at the new Boeing machinists union’s apprentice training center on Friday, June 6, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Boeing Machinists union training center opens in Everett

The new center aims to give workers an inside track at Boeing jobs.

Some SnoCo stores see shortages after cyberattack on grocery supplier

Some stores, such as Whole Foods and US Foods CHEF’STORE, informed customers that some items may be temporarily unavailable.

People take photos and videos as the first Frontier Arlines flight arrives at Paine Field Airport under a water cannon salute on Monday, June 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Water cannons salute Frontier on its first day at Paine Field

Frontier Airlines joins Alaska Airlines in offering service Snohomish County passengers.

Amit B. Singh, president of Edmonds Community College. 201008
Edmonds College and schools continue diversity programs

Educational diversity programs are alive and well in Snohomish County.

A standard jet fuel, left, burns with extensive smoke output while a 50 percent SAF drop-in jet fuel, right, puts off less smoke during a demonstration of the difference in fuel emissions on Tuesday, March 28, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Sustainable aviation fuel center gets funding boost

A planned research and development center focused on sustainable aviation… Continue reading

Helion's 6th fusion prototype, Trenta, on display on Tuesday, July 9, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Helion celebrates smoother path to fusion energy site approval

Helion CEO applauds legislation signed by Gov. Bob Ferguson expected to streamline site selection process.

Pharmacist John Sontra and other employees work on calling customers to get their prescriptions transferred to other stores from the Bartell Drugs Pharmacy on Hoyt Avenue on Wednesday, July 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Bartell Drugs location shutters doors in Everett

John Sontra, a pharmacist at the Hoyt Avenue address for 46 years, said Monday’s closure was emotional.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.